- Home
- ยป
- Our Products
- »
- Pharmaceutical Injectable - 1
Pharmaceutical Injectable - 1
Thioark Glutathione 600mg Injectgion
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 600 mg |
| Composition | Glutathione 600 mg |
| Brand Name | Thioark 600mg |
| Manufacturer By | Monark Critical Care |
| Usage | Liver disease |
| Pack Size | 1 Injection in 1 Vial |
Overview: Thioark is an injectable formulation containing Glutathione, a potent antioxidant naturally found in the body. It plays a critical role in cellular protection, detoxification, and immune function.
Indications:- Antioxidant Therapy: Used for reducing oxidative stress in various medical conditions.
- Detoxification: Supports detoxification processes, particularly in liver health.
- Skin Health: Sometimes used in aesthetic medicine for skin lightening and improving overall skin tone.
Glutathione works by neutralizing free radicals, reducing oxidative stress, and helping to regenerate other antioxidants in the body. It also aids in the detoxification of harmful substances in the liver.
Dosage and Administration:- Dosage: The typical dosage for adults can vary based on the indication, but a common regimen may involve 600 mg administered via intravenous injection. Specific dosing should be determined by a healthcare provider based on individual needs.
- Administration: Should be administered by a healthcare professional, usually through slow intravenous infusion to avoid potential side effects.
- Common Side Effects: May include:
- Injection site reactions (pain, swelling)
- Gastrointestinal discomfort (nausea, diarrhea)
- Serious Side Effects: Rare but can include:
- Allergic reactions
- Anaphylaxis (very rare)
- Hypersensitivity: Should not be used in individuals with known allergies to Glutathione or any components of the formulation.
- Monitoring: Patients should be monitored for any adverse reactions during and after administration.
- Pregnancy and Breastfeeding: Consult a healthcare provider before use in pregnant or breastfeeding women.
Inform your healthcare provider about all medications being taken, as some drugs may affect Glutathione levels or interact with its effects.
Storage Instructions:Store at room temperature, protected from light. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Thioark and the importance of following the prescribed regimen.
- Discuss potential side effects and the importance of reporting any unusual symptoms during or after the injection.
- Emphasize the need for follow-up appointments to monitor treatment effectiveness.
Thioark (Glutathione) 600 mg Injection is an effective antioxidant therapy with various medical and aesthetic applications. Always consult healthcare professionals for personalized medical advice and treatment plans.
Dotamin 250Mg injection
Product Brochure
| Strength | 250 mg |
| Pack Size | 5 ml |
| Brand Name | Dotamin 250Mg Injection |
| Manufactured By | Neon Laboratories Ltd |
| Composition | Dobutamine 250mg |
| Usage/Application | Cardiovascular Breakdown |
Overview: Dotamin typically contains the active ingredient Dopamine, which is a catecholamine used in medical settings primarily for its cardiovascular effects. It is often administered in critical care to manage specific conditions related to heart function and blood circulation.
Indications:- Shock: Used to treat various types of shock, including cardiogenic and septic shock, to improve blood flow and cardiac output.
- Heart Failure: May be used in certain cases of heart failure to enhance cardiac contractility.
- Hypotension: Used to increase blood pressure in acute settings.
Dopamine acts on dopamine receptors and adrenergic receptors in the body, depending on the dose:
- Low doses (1-5 mcg/kg/min): Primarily stimulate dopaminergic receptors, leading to vasodilation in renal and mesenteric blood vessels.
- Moderate doses (5-10 mcg/kg/min): Activate β1-adrenergic receptors, increasing heart rate and myocardial contractility.
- High doses (above 10 mcg/kg/min): Stimulate α-adrenergic receptors, causing vasoconstriction and increased blood pressure.
- Dosage: The exact dosage will depend on the patient's condition and response to treatment. It is typically initiated at a low dose and titrated based on clinical response.
- Administration: Dotamin is administered via intravenous infusion under close medical supervision.
- Common Side Effects: Nausea, vomiting, palpitations, and headache.
- Serious Side Effects: Tachycardia, arrhythmias, hypertension, and tissue ischemia (especially with extravasation).
- Pheochromocytoma: Patients with this tumor should avoid dopamine administration.
- Uncontrolled Ventricular Fibrillation: Should not be used in patients with this condition.
- Monitoring: Continuous monitoring of cardiac function and blood pressure is essential during administration.
- Extravasation Risk: Care should be taken to avoid extravasation, which can cause tissue necrosis.
Inform your healthcare provider about all medications you are taking, especially those affecting heart rate or blood pressure, as they may interact with dopamine.
Storage Instructions:Store at room temperature, protected from light. Follow any specific storage recommendations provided with the medication.
Patient Counseling:- Educate patients and caregivers about the purpose of Dotamin and its administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Emphasize the need for close monitoring during treatment.
Dotamin 250 mg Injection is a critical medication used in managing shock and heart failure, requiring careful administration and monitoring. Always consult healthcare professionals for personalized medical advice and treatment plans.
Tenecterel Tenecteplase 40mg injection
Product Brochure
| Strength | 40 mg |
| Packaging Size | 1 Injection in 1 vial |
| Composition | Tenecteplase 40 mg |
| Brand Name | Tenecterel 40 mg |
| Manufacturer | Reliance Life Sciences |
| Treatment | Acute Myocardial Infarction (Heart attack) |
Overview: Tenecterel is an injectable formulation containing Tenecteplase, a thrombolytic agent used primarily for the treatment of acute myocardial infarction (AMI), particularly in patients with ST-elevation myocardial infarction (STEMI).
Indications:- Acute Myocardial Infarction (AMI): Used to dissolve blood clots in the coronary arteries, helping restore blood flow to the heart muscle during a heart attack.
Tenecteplase is a modified form of tissue plasminogen activator (tPA). It works by converting plasminogen to plasmin, which breaks down fibrin in blood clots, facilitating the rapid restoration of blood flow.
Dosage and Administration:- Dosage: The dosing is typically weight-based, with the common administration as a single intravenous bolus:
- For patients weighing ≤ 90 kg: 30 mg
- For patients weighing > 90 kg: 40 mg
- Administration: Should be given in a controlled healthcare setting, allowing for monitoring of the patient during and after the infusion.
- Common Side Effects:
- Bleeding (including minor bruising, nosebleeds)
- Nausea
- Dizziness
- Serious Side Effects: Rare but may include:
- Severe hemorrhage
- Anaphylactic reactions
- Active Bleeding: Should not be administered to patients with ongoing bleeding.
- Recent Surgery or Trauma: Avoid in patients who have had recent major surgeries or significant trauma.
- Uncontrolled Hypertension: Not recommended for patients with severely high blood pressure.
- Monitoring: Patients must be closely monitored for any signs of bleeding during and after administration.
- Renal Impairment: Use with caution in patients with kidney problems.
Inform healthcare providers about all medications being taken, especially anticoagulants and antiplatelet agents, as these can increase the risk of bleeding.
Storage Instructions:Store at room temperature, away from light. Keep out of reach of children.
Patient Counseling:- Explain the role of Tenecterel in treating heart attacks and its mechanism of action.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially those related to bleeding.
- Highlight the necessity for follow-up appointments to monitor treatment effectiveness and safety.
Tenecterel (Tenecteplase) 40 mg Injection is an effective option for managing acute myocardial infarction, aiding in the quick dissolution of blood clots. Always consult healthcare professionals for personalized medical advice and treatment plans.
Lek pamidol 300mg Iopamidol injection
Product Brochure
| Strength | 300 mg |
| Brand | Lek-Pamidol 300mg |
| Composition | Lopamidol 300mg |
| Packaging Size | 50 ml in 1 vial |
| Manufactured By | J B Chemicals and Pharmaceuticals Ltd |
| Usage / Application | Diagnostic Agent |
Overview: Lek Pamidol is a contrast agent containing Iopamidol, used primarily in radiographic imaging procedures to enhance the visibility of internal structures. It is especially helpful in computed tomography (CT) scans and other imaging studies.
Indications:- Diagnostic Imaging: Used for various imaging studies, including:
- CT scans of the head, chest, abdomen, and pelvis.
- Angiography to visualize blood vessels.
- Intravenous urography for urinary tract imaging.
Iopamidol is an iodinated contrast medium that absorbs X-rays more effectively than surrounding tissues. This allows for clearer imaging of blood vessels and organs by creating a contrast that highlights these areas during imaging procedures.
Dosage and Administration:- Dosage: The specific dosage is determined based on the type of procedure, the patient's condition, and other factors. Typically, 300 mg is used for certain imaging studies.
- Administration: Administered via intravenous injection or infusion, usually under medical supervision in a healthcare setting.
- Common Side Effects: May include:
- Nausea
- Vomiting
- Warmth or flushing at the injection site
- Headache
- Serious Side Effects: Rare but possible, including:
- Allergic reactions (e.g., rash, difficulty breathing)
- Contrast-induced nephropathy (kidney impairment)
- Thyroid dysfunction
- Hypersensitivity: Known allergy to Iopamidol or other iodinated contrast agents.
- Severe Renal Impairment: Caution is advised in patients with significant kidney dysfunction.
- Hydration: Adequate hydration before and after the procedure is important to help prevent kidney-related side effects.
- Monitoring: Patients should be closely monitored during and after administration, especially those with a history of allergies or kidney issues.
Inform your healthcare provider about all medications you are taking, particularly those affecting kidney function or other contrast agents.
Storage Instructions:Store at room temperature, protected from light and moisture. Follow any specific storage instructions provided with the medication.
Patient Counseling:- Explain the purpose of Lek Pamidol and its role in diagnostic imaging.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Advise patients to inform the healthcare team about any previous reactions to contrast agents.
Lek Pamidol (Iopamidol) 300 mg Injection is an essential contrast medium for improving the quality of diagnostic imaging. Always consult healthcare professionals for personalized medical advice and treatment plans.
Danogen 200 Mg Injection
Product Brochure
| Strength | 200 mg |
| Packaging Size | 10*10 Capsules |
| Composition | Danazol 200 mg |
| Treatment | Benign Fibrocystic Breast Diseas |
| Brand Name | Danogen 200 mg |
| Manufactured By | Cipla Ltd |
Overview: Danogen is an injectable formulation of Danazol, a synthetic steroid that is primarily used to treat endometriosis and fibrocystic breast disease. It has anti-estrogenic and androgenic properties.
Indications:- Endometriosis: Used to relieve pain and other symptoms associated with endometriosis.
- Fibrocystic Breast Disease: Helps in reducing breast pain and tenderness associated with this condition.
- Hereditary Angioedema: Occasionally used for prevention and treatment of attacks.
Danazol works by inhibiting the production of gonadotropins (LH and FSH) from the pituitary gland, which decreases estrogen production. This leads to a reduction in the growth of endometrial tissue and alleviates associated symptoms.
Dosage and Administration:- Dosage: The typical dosage for endometriosis may vary, but common regimens involve 200 mg administered intramuscularly, often given every two to four weeks, depending on the condition being treated.
- Administration: Should be administered by a healthcare professional.
- Common Side Effects: May include:
- Weight gain
- Acne
- Changes in menstrual cycle
- Mood changes (e.g., depression, anxiety)
- Serious Side Effects: Rare but can include:
- Liver function abnormalities
- Thromboembolic events
- Allergic reactions
- Pregnancy: Should not be used during pregnancy due to potential harm to the fetus.
- Hypersensitivity: Known allergy to Danazol or any of its components.
- Active Liver Disease: Caution in patients with liver dysfunction.
- Monitoring: Liver function tests may be necessary during treatment, especially in patients with a history of liver disease.
- Hormonal Effects: Patients should be monitored for signs of androgenic side effects.
Inform your healthcare provider about all medications being taken, especially those affecting liver function and hormonal therapies.
Storage Instructions:Store at room temperature, away from light and moisture. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Danogen and its administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Emphasize adherence to follow-up appointments for monitoring.
Danogen (Danazol) 200 mg Injection is an effective treatment option for managing endometriosis and fibrocystic breast disease. Always consult healthcare professionals for personalized medical advice and treatment plans.
Tenectelex Tenecteplase 40mg injection
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 40 mg |
| Packaging Size | 1 Injection in 1 vial |
| Brand Name | Tenectelex 40 mg |
| Manufacturer | Abbott Healthcare Private Limited |
| Uses | Heart attack |
Overview: Tenectelex is an injectable formulation containing Tenecteplase, a thrombolytic agent used for the treatment of acute myocardial infarction (heart attack).
Indications:- Acute Myocardial Infarction (AMI): Indicated for the treatment of ST-elevation myocardial infarction (STEMI) to dissolve blood clots in the coronary arteries.
Tenecteplase is a tissue plasminogen activator (tPA) that works by converting plasminogen to plasmin, leading to the breakdown of fibrin in blood clots. This helps restore blood flow to the heart muscle.
Dosage and Administration:- Dosage: The typical dosing for Tenectelex is based on the patient's weight, usually administered as a single intravenous bolus. The specific dose may vary, but a common regimen is 40 mg for patients weighing over 90 kg.
- Administration: Should be given by healthcare professionals in a controlled setting, such as a hospital, to monitor for complications.
- Common Side Effects: May include:
- Bleeding complications (e.g., bruising, nosebleeds)
- Nausea
- Vomiting
- Serious Side Effects: Rare but can include:
- Severe hemorrhage
- Anaphylaxis
- Active Bleeding: Contraindicated in patients with ongoing bleeding or bleeding disorders.
- Recent Surgery or Trauma: Should not be used in patients who have had recent major surgery or significant trauma.
- Severe Hypertension: Patients with uncontrolled high blood pressure should avoid this medication.
- Monitoring: Patients should be closely monitored for signs of bleeding during and after administration.
- Renal Impairment: Use with caution in patients with renal impairment.
Inform your healthcare provider about all medications being taken, especially anticoagulants or antiplatelet drugs.
Storage Instructions:Store at room temperature, protected from light. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Tenectelex and its role in treating heart attacks.
- Discuss potential side effects, especially those related to bleeding, and the importance of reporting any unusual symptoms.
- Emphasize adherence to follow-up appointments for monitoring treatment effectiveness and safety.
Tenectelex (Tenecteplase) 40 mg Injection is an effective thrombolytic agent used in the management of acute myocardial infarction. Always consult healthcare professionals for personalized medical advice and treatment plans.
Lmwx 20 Enoxaparin Injection 20 mg 0.2 ml
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 20 mg |
| Pack Size | 0.2 ml |
| Composition | Enoxaparin 20 mg/ 0.2 ml |
| Brand | Lmwx 20 |
| Manufactured By | Abbott |
| Treatment | Treatment and avoidance of Blood clusters |
Overview: LMWX 20 contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used primarily for its anticoagulant properties. It is commonly utilized for the prevention and treatment of thromboembolic disorders.
Indications:- Prevention of Deep Vein Thrombosis (DVT): Used in patients undergoing surgery (e.g., orthopedic or abdominal surgery) to reduce the risk of DVT.
- Treatment of DVT and Pulmonary Embolism (PE): Effective in managing existing blood clots.
- Acute Coronary Syndrome: Sometimes used in the management of unstable angina or non-ST elevation myocardial infarction (NSTEMI).
Enoxaparin works by inhibiting Factor Xa and to a lesser extent Factor IIa (thrombin), which prevents the formation of blood clots. It enhances the activity of antithrombin III, leading to decreased blood coagulation.
Dosage and Administration:- Dosage: The typical dosage for DVT prophylaxis is 20 mg administered subcutaneously once daily. For treatment of DVT or PE, dosages may vary based on the patient's condition and response.
- Administration: Injected subcutaneously, usually in the abdominal area. It is important to alternate injection sites to minimize irritation.
- Common Side Effects: May include:
- Injection site reactions (pain, redness, swelling)
- Nausea
- Bleeding or bruising
- Serious Side Effects: Rare but can include:
- Thrombocytopenia (low platelet count)
- Severe allergic reactions
- Major bleeding events
- Active Bleeding: Should not be used in patients with active bleeding or severe renal impairment.
- Hypersensitivity: Known allergy to Enoxaparin or other heparins.
- Monitoring: Regular monitoring of platelet counts and renal function may be necessary during treatment.
- Bleeding Risk: Patients should be informed of the signs of bleeding and instructed to seek immediate medical attention if they occur.
Inform your healthcare provider about all medications being taken, particularly other anticoagulants, antiplatelet agents, and NSAIDs.
Storage Instructions:Store at room temperature, away from light. Do not freeze. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of LMWX 20 and its proper administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially signs of bleeding.
- Emphasize adherence to the prescribed regimen and regular follow-up appointments.
LMWX 20 (Enoxaparin) Injection is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Always consult healthcare professionals for personalized medical advice and treatment plans.
Edastar Edaravone Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 1.5 mg |
| Packaging Size | 20 ml Injection in 1 Vial |
| Composition | Edaravone 1.5mg |
| Brand | Edastar 1.5mg Tablet |
| Manufacturer | Lupin Ltd |
| Treatment | Amyotrophic Lateral Sclerosis (ALS) |
Overview: Edastar typically contains Edaravone, a medication primarily used to treat amyotrophic lateral sclerosis (ALS) and may also be used for other neuroprotective purposes. It is known for its antioxidant properties.
Indications:- Amyotrophic Lateral Sclerosis (ALS): Used to slow the decline in physical function in patients with ALS.
- Acute Ischemic Stroke: Sometimes utilized in the context of stroke management to reduce oxidative stress.
Edaravone works by scavenging free radicals and reducing oxidative stress, which can damage cells. By protecting neurons from oxidative damage, it aims to preserve nerve function and slow disease progression.
Dosage and Administration:- Dosage: The standard dosage for ALS treatment is typically 1.5 mg administered intravenously over a specific period (usually around 60 minutes). The regimen may vary based on the patient’s condition and treatment response.
- Administration: It is crucial to follow the healthcare provider's instructions regarding infusion rates and schedules.
- Common Side Effects: May include:
- Headache
- Contusions (bruising)
- Rash
- Serious Side Effects: Rare but can include:
- Allergic reactions (e.g., anaphylaxis)
- Liver function abnormalities
- Hypersensitivity: Known allergy to Edaravone or any of its components.
- Severe Liver Impairment: Caution is advised in patients with liver issues.
- Monitoring: Liver function tests may be recommended during treatment.
- Allergic Reactions: Patients should be monitored for signs of allergic reactions during and after administration.
Inform your healthcare provider about all medications you are taking, especially those affecting liver function.
Storage Instructions:Store at room temperature, away from light and moisture. Follow any specific storage recommendations provided with the medication.
Patient Counseling:- Educate patients about the purpose of Edastar and its administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Encourage adherence to follow-up appointments for monitoring.
Edastar (Edaravone) 1.5 mg is an important treatment option for managing ALS and other conditions related to oxidative stress. Always consult healthcare professionals for personalized medical advice and treatment plans.
Lmwx 40 Enoxaparin Injection 40 Mg 0.4 Ml
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 40 mg |
| Pack Size | 0.4 ml |
| Packaging Size | 0.4 ml in 1 prefilled syringe |
| Composition | Enoxaparin 40 mg/0.4 ml |
| Brand | Lmwx 40 |
| Manufactured By | Abbott |
| Treatment | Treatment and avoidance of Blood clusters |
Overview: LMWX 40 contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used for its anticoagulant properties. It is commonly prescribed to prevent and treat thromboembolic disorders.
Indications:- Prevention of Deep Vein Thrombosis (DVT): Used in patients undergoing surgery, particularly orthopedic and abdominal surgeries, to reduce the risk of DVT.
- Treatment of DVT and Pulmonary Embolism (PE): Effective for managing existing blood clots.
- Acute Coronary Syndrome: Sometimes utilized in the management of unstable angina or non-ST elevation myocardial infarction (NSTEMI).
Enoxaparin inhibits Factor Xa and, to a lesser extent, Factor IIa (thrombin), which prevents the formation of blood clots. It enhances the action of antithrombin III, leading to decreased blood coagulation.
Dosage and Administration:- Dosage: The typical dosage for DVT prophylaxis is 40 mg administered subcutaneously once daily. For treatment of DVT or PE, the dosage may vary based on the specific clinical scenario.
- Administration: Injected subcutaneously, usually in the abdominal region. It is important to alternate injection sites to reduce irritation.
- Common Side Effects: May include:
- Injection site reactions (pain, redness, swelling)
- Nausea
- Bleeding or bruising
- Serious Side Effects: Rare but can include:
- Thrombocytopenia (low platelet count)
- Severe allergic reactions
- Major bleeding events
- Active Bleeding: Should not be used in patients with active bleeding or severe renal impairment.
- Hypersensitivity: Known allergy to Enoxaparin or other heparins.
- Monitoring: Regular monitoring of platelet counts and renal function may be necessary during treatment.
- Bleeding Risk: Patients should be informed about the signs of bleeding and instructed to seek immediate medical attention if they occur.
Inform your healthcare provider about all medications being taken, especially other anticoagulants, antiplatelet agents, and non-steroidal anti-inflammatory drugs (NSAIDs).
Storage Instructions:Store at room temperature, away from light. Do not freeze. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of LMWX 40 and its proper administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially signs of bleeding.
- Emphasize adherence to the prescribed regimen and regular follow-up appointments.
LMWX 40 (Enoxaparin) Injection is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Always consult healthcare professionals for personalized medical advice and treatment plans.
Atracuriumbesylate Artacil 100 mg
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 100mg/10ml |
| Packaging Size | 10ml |
| Composition | Atracuriumbesylate 100mg |
| Brand Name | Atracil 100mg |
| Manufactured By | Neon Laboratories Ltd |
| Usage/Application | Skeletal muscle relaxation during surgery |
Overview: Artacil contains Atracurium Besylate, a neuromuscular blocking agent used during anesthesia to facilitate intubation and provide muscle relaxation during surgery or mechanical ventilation.
Indications:- Surgical Anesthesia: Used to induce muscle relaxation for surgical procedures.
- Intubation: Facilitates the placement of an endotracheal tube.
- Mechanical Ventilation: Provides muscle relaxation in patients requiring mechanical ventilation.
Atracurium works by blocking the transmission of nerve impulses to the muscles by competitively inhibiting the action of acetylcholine at the neuromuscular junction, resulting in muscle paralysis.
Dosage and Administration:- Dosage: The typical dosage for adults ranges from 0.3 to 0.6 mg/kg, administered intravenously. The exact dosage may depend on the patient's individual response and the surgical procedure.
- Administration: Administered by a healthcare professional through slow intravenous injection.
- Common Side Effects: May include:
- Hypotension
- Flushing
- Respiratory depression
- Serious Side Effects: Rare but can include:
- Anaphylaxis
- Prolonged neuromuscular blockade
- Cardiovascular complications
- Hypersensitivity: Known allergy to Atracurium or other neuromuscular blockers.
- Severe Respiratory Insufficiency: Caution in patients with compromised respiratory function.
- Monitoring: Patients should be monitored for respiratory function and neuromuscular function during and after administration.
- Renal and Hepatic Impairment: Caution is advised in patients with liver or kidney dysfunction, although Atracurium is metabolized by non-specific plasma esterases and should be safe in these patients.
Inform your healthcare provider about all medications being taken, particularly other neuromuscular blockers, anesthetics, and medications affecting respiratory function.
Storage Instructions:Store at room temperature, away from light. Protect from freezing. Keep out of reach of children.
Patient Counseling:- Educate patients that Artacil is used in a controlled setting, typically during surgery.
- Discuss the purpose of the medication and the importance of monitoring during the procedure.
- Explain potential side effects and the importance of reporting any unusual symptoms to the healthcare team.
Artacil (Atracurium Besylate) 100 mg Injection is an effective neuromuscular blocker used in anesthesia. Always consult healthcare professionals for personalized medical advice and treatment plans.
LMWX 60 Enoxaparin 60mg 0.6ml
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 60 mg |
| Pack Size | 0.6 ml |
| Composition | Enoxaparin 60 mg/.06 ml |
| Manufacturer | Abbott |
| Brand | Lmwx 60 mg/0.6 ml |
| Treatment | Treatment and avoidance of Blood clusters |
Overview: LMWX 60 contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used primarily for its anticoagulant effects. It is indicated for the prevention and treatment of thromboembolic disorders.
Indications:- Prevention of Deep Vein Thrombosis (DVT): Particularly in patients undergoing surgical procedures, such as orthopedic or abdominal surgeries.
- Treatment of DVT and Pulmonary Embolism (PE): Effective in managing existing blood clots.
- Acute Coronary Syndrome: Sometimes utilized in the management of unstable angina and non-ST elevation myocardial infarction (NSTEMI).
Enoxaparin selectively inhibits Factor Xa and, to a lesser extent, Factor IIa (thrombin), which helps prevent the formation of blood clots. This action reduces the risk of thromboembolic events.
Dosage and Administration:- Dosage: The standard dose for DVT prophylaxis is typically 40 mg once daily. For treatment of DVT or PE, the dosage may vary and could be around 1 mg/kg every 12 hours, depending on the clinical scenario.
- Administration: Injected subcutaneously, usually in the abdominal region. It's important to rotate injection sites to minimize irritation.
- Common Side Effects: May include:
- Injection site reactions (pain, redness, swelling)
- Nausea
- Bleeding or bruising
- Serious Side Effects: Rare but can include:
- Thrombocytopenia (low platelet count)
- Severe allergic reactions
- Major bleeding events
- Active Bleeding: Should not be used in patients with active bleeding or severe renal impairment.
- Hypersensitivity: Known allergy to Enoxaparin or other heparins.
- Monitoring: Regular monitoring of platelet counts and renal function may be necessary during treatment.
- Bleeding Risk: Patients should be informed about the signs of bleeding and instructed to seek immediate medical attention if they occur.
Inform your healthcare provider about all medications being taken, particularly other anticoagulants, antiplatelet agents, and non-steroidal anti-inflammatory drugs (NSAIDs).
Storage Instructions:Store at room temperature, away from light. Do not freeze. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of LMWX 60 and its proper administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially signs of bleeding.
- Emphasize adherence to the prescribed regimen and regular follow-up appointments.
LMWX 60 (Enoxaparin) Injection is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Always consult healthcare professionals for personalized medical advice and treatment plans.
LMWX 80 Enoxaperin 80mg 0.8ml
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 80 mg |
| Pack Size | 0.8 ml |
| Composition | Enoxaparin 80 mg/0.8 ml |
| Brand | Lmxw 80 |
| Manufactured | Abbott |
| Treatment | Treatment and avoidance of Blood clusters |
Overview: LMWX 80 contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) commonly used for its anticoagulant properties. It is indicated for both the prevention and treatment of thromboembolic disorders.
Indications:- Prevention of Deep Vein Thrombosis (DVT): Especially in patients undergoing major orthopedic or abdominal surgeries.
- Treatment of DVT and Pulmonary Embolism (PE): Effective for managing existing blood clots.
- Acute Coronary Syndrome: Used in the management of unstable angina and non-ST elevation myocardial infarction (NSTEMI).
Enoxaparin selectively inhibits Factor Xa and, to a lesser extent, Factor IIa (thrombin), which prevents the formation of blood clots. This anticoagulant effect helps to reduce the risk of thromboembolic events.
Dosage and Administration:- Dosage: The typical dosage for DVT prophylaxis is 40 mg once daily, while for treatment of DVT or PE, the dosage can be 1 mg/kg every 12 hours or as directed by a healthcare provider.
- Administration: Injected subcutaneously, typically in the abdominal area. It's important to rotate injection sites to minimize irritation.
- Common Side Effects: May include:
- Injection site reactions (pain, redness, swelling)
- Nausea
- Bleeding or bruising
- Serious Side Effects: Rare but can include:
- Thrombocytopenia (low platelet count)
- Severe allergic reactions
- Major bleeding events
- Active Bleeding: Should not be used in patients with active bleeding or severe renal impairment.
- Hypersensitivity: Known allergy to Enoxaparin or other heparins.
- Monitoring: Regular monitoring of platelet counts and renal function may be necessary during treatment.
- Bleeding Risk: Patients should be informed about the signs of bleeding and instructed to seek immediate medical attention if they occur.
Inform your healthcare provider about all medications being taken, especially other anticoagulants, antiplatelet agents, and non-steroidal anti-inflammatory drugs (NSAIDs).
Storage Instructions:Store at room temperature, away from light. Do not freeze. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of LMWX 80 and its proper administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially signs of bleeding.
- Emphasize adherence to the prescribed regimen and regular follow-up appointments.
LMWX 80 (Enoxaparin) Injection is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Always consult healthcare professionals for personalized medical advice and treatment plans.
Fondared 2.5 ml Injection
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 2.5mg/0.5ml |
| Composition | Fondaparinux 2.5mg/0.5ml |
| Packaging Size | 0.5 ml Injection in 1 Piece |
| Brand Name | Fondared 2.5ml injection |
| Manufactured By | Dr Reddy's Laboratories Ltd |
| Usage | Prevention of Blood Clot Formation |
Overview: Fondared is a brand of Fondaparinux, an anticoagulant medication used to prevent and treat thromboembolic disorders. It is a synthetic pentasaccharide that inhibits Factor Xa, a key enzyme in the coagulation cascade.
Indications:- Prevention of Venous Thromboembolism (VTE): Used in patients undergoing surgery, particularly orthopedic or abdominal procedures.
- Treatment of Deep Vein Thrombosis (DVT): Effective for treating DVT and pulmonary embolism (PE).
- Acute Coronary Syndrome: Sometimes used in conjunction with other therapies for patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).
Fondaparinux selectively inhibits Factor Xa, preventing the conversion of prothrombin to thrombin, which is essential for the formation of blood clots. This anticoagulant effect helps reduce the risk of thromboembolic events.
Dosage and Administration:- Dosage: The specific dosage varies based on the indication. For DVT prophylaxis after surgery, a common dose is 2.5 mg subcutaneously once daily.
- Administration: Administered via subcutaneous injection, typically in the abdominal area. It should be injected at the same time each day for consistency.
- Common Side Effects: May include:
- Injection site reactions (pain, redness, swelling)
- Nausea
- Anemia
- Serious Side Effects: Rare but can include:
- Severe bleeding
- Thrombocytopenia (low platelet count)
- Allergic reactions
- Active Bleeding: Should not be used in patients with active bleeding or severe renal impairment.
- Hypersensitivity: Known allergy to Fondaparinux or any components of the formulation.
- Monitoring: Regular monitoring of renal function and platelet counts is advised during treatment.
- Bleeding Risk: Patients should be informed of the signs of bleeding and advised to seek immediate medical attention if they occur.
Inform your healthcare provider about all medications being taken, especially other anticoagulants, antiplatelet agents, and non-steroidal anti-inflammatory drugs (NSAIDs).
Storage Instructions:Store at room temperature, protected from light. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Fondared and its proper administration.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially bleeding.
- Emphasize the need for adherence to the prescribed regimen and regular follow-up appointments.
Fondared (Fondaparinux) Injection is an effective anticoagulant used for the prevention and treatment of thromboembolic disorders. Always consult healthcare professionals for personalized medical advice and treatment plans.